Electron Beam Linear Accelerators Market Size

Electron Beam Linear Accelerators Market size was valued at USD 709.2 million in 2023 and is estimated to grow at 5.7% CAGR from 2024 to 2032. Rise in the prevalence of cancer related disorders, coupled with increasing applications in medical domain, is driving the market growth. According to the International Agency for Research on Cancer (IARC), lung cancer ranked as the most commonly occurring cancer worldwide in 2022, with approximately 2.5 million new cases reported globally.

This accounted for over 12 percent of all new cancer cases and led to 1.8 million deaths, representing 18.9 % of all cancer-related deaths. Electron beam linear accelerators play a crucial role in cancer treatment by delivering high-energy radiation beams precisely to tumor sites, minimizing damage to surrounding healthy tissues. As the incidence of cancer continues to increase globally, the demand for linacs is expected to grow in parallel to meet the needs of cancer patients for effective radiation therapy.

Electron beam linear accelerators are medical devices used in radiation therapy for cancer treatment. They accelerate electrons to high energies and direct them into a target material to produce high-energy X-rays or electron beams. These beams are then used to deliver precise doses of radiation to the tumor while sparing surrounding healthy tissue.